News | November 10, 2021
India Pharmaceutical Market grows 5% in October 2021
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
Ind-Ra continues to expect IPM’s revenue to grow over 12% yoy in FY22
A Sanofi R&D executive will join the Gyroscope Clinical Advisory Board to advise on matters related to the development of GT005 for geographic atrophy (GA).
The drug helps in managing cholesterol
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
The acquisition expands Takeda’s immuno-oncology and innate immune cell therapy portfolio with novel platforms leveraging T cells for the potential treatment of solid tumours and haematological malignancies
Kymriah, the first-ever FDA-approved CAR-T cell therapy, is currently available in 30 countries in one or more indications
It is the first integrated digital PCR solution ideal for oncology, cell and gene therapy development
Acute therapies continue to report strong growth compared to chronic ones.
The collaboration aims to deliver greater insights to the oncology fraternity, predict patient therapy responses and enable therapy selection resulting in optimal treatment outcomes.
It is the first company to launch Remogliflozin, Vildagliptin and Metformin combination
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
